PhD Eng.
Magdalena Goncerz graduated from the Krakow University of Technology in the field of biotechnology. In her master’s thesis, she worked on Controlled Drug Delivery Systems (CDDS). Currently, she is preparing a doctoral dissertation in this field of nanotechnology. Its main research areas are the physicochemistry of colloidal systems, in particular the physicochemical characteristics of dendrimers and proteins in the context of their interactions with anticancer drugs.
2019 – 2024 – PhD (Chemistry) – Krakow School of Interdisciplinary PhD Studies at Jerzy Haber Institute of Catalysis and Surface Chemistry, PAS
2018 – 2019 – Master of Science in Biotechnology (Industrial and Environmental Biotechnology), the Department of Chemical Engineering and Technology at Cracow University of Technology
2014 – 2018 – Engineer’s Degree in Biotechnology (Industrial and Environmental Biotechnology), the Department of Chemical Engineering and Technology at Cracow University of Technology
March 2022 – May 2024
Participation in OPUS 21, ST-5, 2021/41/B/ST5/02233 program Structure and Function of the Protein Corona on the Surface of Nanoparticles funded by the National Science Centre in Poland at Jerzy Haber Institute of Catalysis and Surface Chemistry, PAS
February 2023 – March 2023
Research Internship
Department of Physics, University of Glasgow, Scotland, UK.
November 2021 – December 2021
Research Internship
Department of Chemical and Geological Sciences, University of Cagliari, Italy.
September 2021 – October 2021
Research Internship
Department of Chemical and Geological Sciences, University of Cagliari, Italy.
November 2019 – June 2021
Participation in OPUS 12, ST-5, 2016/23/B/ST5/02788 program Dendrimers as a platform for the design of biologically active carriers funded by the National Science Centre in Poland at Jerzy Haber Institute of Catalysis and Surface Chemistry, PAS
Jachimska B.* Goncerz M., Wolski P., Meldrum C., Lustyk Ł., Panczyk T., “Theoretical and Experimental Analyses of the Interfacial Mechanism of Dendrimer-Doxorubicin Complex Formation”, Molecular Pharmaceutics, 2024
Szota M., Szwedowicz U., Rembiałowska N., Janicka-Klos A., Doveiko D., Chen Y., Kulbacka J., Jachimska B.* “Dendrimer Platforms for Targeted Doxorubicin Delivery—Physicochemical Properties in Context of Biological Responses” International Journal of Molecular Sciences 2024, 25(13), 7201
Adamczyk O., Szota M., Rakowski K., Prochownik M., Doveiko D., Chen Y., Jachimska B.* “Bovine Serum Albumin as a Platform for Designing Biologically Active Nanocarriers—Experimental and Computational Studies” International Journal of Molecular Sciences 2024, 25, 37
Tworek P., Rakowski K., Szota M., Lekka M., Jachimska B.*, “Changes in Secondary Structure and Properties of Bovine Serum Albumin as a Result of Interactions with Gold Surface” ChemPhysChem, 2024, 25(2):e202300505.
Szota M. and Jachimska B.*, “Effect of Alkaline Conditions on Forming an Effective G4.0 PAMAM Complex with Doxorubicin” Pharmaceutics, 2023, 15(3), 875
Szota M., Wolski P., Carucci C., Cesare F. M., Gurgul J., Panczyk T., Salis A., Jachimska B.*, “Effect of Ionization Degree of Poly(amidoamine) Dendrimer and 5-Fluorouracil on the Efficiency of Complex Formation—A Theoretical and Experimental Approach” International Journal of Molecular Sciences, 2023, 24, 819
A. Sobiepanek, P. D. Kowalska, M. Szota, T. Grzywa, J. Nowak, P. K. Włodarski, R. Galus, B. Jachimska, T. Kobiela, “Novel diagnostic and prognostic factors for the advanced melanoma based on the glycosylation-related changes studied by biophysical profiling methods,” Biosens. Bioelectron., vol. 203, no. October 2021, p. 114046, 2022, doi: 10.1016/j.bios.2022.114046.
Szota, M.; Reczyńska-Kolman, K.; Pamuła, E.; Michel, O.; Kulbacka, J.; Jachimska, B. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies. Int. J. Mol. Sci. 2021, 22, 11167. https://doi.org/10.3390/ijms222011167
